69.88 USD
-0.94 (-1.33%)
Last: Feb 5, 2026, 03:54 PM
DXCM gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. DXCM gets an excellent profitability rating and is at the same time showing great financial health properties. DXCM is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings would make DXCM suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
- DXCM had positive earnings in the past year.
- DXCM had a positive operating cash flow in the past year.
- In the past 5 years DXCM has always been profitable.
- In the past 5 years DXCM always reported a positive cash flow from operatings.
1.2 Ratios
- DXCM's Return On Assets of 9.61% is amongst the best of the industry. DXCM outperforms 93.01% of its industry peers.
- The Return On Equity of DXCM (26.44%) is better than 97.31% of its industry peers.
- With an excellent Return On Invested Capital value of 15.72%, DXCM belongs to the best of the industry, outperforming 95.70% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for DXCM is above the industry average of 8.80%.
- The 3 year average ROIC (11.25%) for DXCM is below the current ROIC(15.72%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.61% | ||
| ROE | 26.44% | ||
| ROIC | 15.72% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
1.3 Margins
- DXCM has a better Profit Margin (15.96%) than 93.01% of its industry peers.
- DXCM's Profit Margin has improved in the last couple of years.
- The Operating Margin of DXCM (18.41%) is better than 90.32% of its industry peers.
- DXCM's Operating Margin has improved in the last couple of years.
- The Gross Margin of DXCM (60.20%) is better than 61.29% of its industry peers.
- DXCM's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.41% | ||
| PM (TTM) | 15.96% | ||
| GM | 60.2% |
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
2. Health
2.1 Basic Checks
- DXCM has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- The number of shares outstanding for DXCM has been increased compared to 1 year ago.
- DXCM has more shares outstanding than it did 5 years ago.
- The debt/assets ratio for DXCM has been reduced compared to a year ago.
2.2 Solvency
- DXCM has an Altman-Z score of 5.15. This indicates that DXCM is financially healthy and has little risk of bankruptcy at the moment.
- With a decent Altman-Z score value of 5.15, DXCM is doing good in the industry, outperforming 77.96% of the companies in the same industry.
- The Debt to FCF ratio of DXCM is 2.36, which is a good value as it means it would take DXCM, 2.36 years of fcf income to pay off all of its debts.
- The Debt to FCF ratio of DXCM (2.36) is better than 85.48% of its industry peers.
- A Debt/Equity ratio of 0.47 indicates that DXCM is not too dependend on debt financing.
- DXCM has a Debt to Equity ratio (0.47) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 2.36 | ||
| Altman-Z | 5.15 |
ROIC/WACC1.62
WACC9.73%
2.3 Liquidity
- DXCM has a Current Ratio of 1.56. This is a normal value and indicates that DXCM is financially healthy and should not expect problems in meeting its short term obligations.
- DXCM has a Current ratio of 1.56. This is in the lower half of the industry: DXCM underperforms 70.97% of its industry peers.
- A Quick Ratio of 1.38 indicates that DXCM should not have too much problems paying its short term obligations.
- DXCM's Quick ratio of 1.38 is in line compared to the rest of the industry. DXCM outperforms 40.32% of its industry peers.
- DXCM does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.38 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 9.41% over the past year.
- Measured over the past years, DXCM shows a very strong growth in Earnings Per Share. The EPS has been growing by 29.25% on average per year.
- DXCM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.21%.
- DXCM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.27% yearly.
EPS 1Y (TTM)9.41%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%35.56%
Revenue 1Y (TTM)14.21%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%21.64%
3.2 Future
- DXCM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.05% yearly.
- Based on estimates for the next years, DXCM will show a quite strong growth in Revenue. The Revenue will grow by 13.28% on average per year.
EPS Next Y27.38%
EPS Next 2Y23.51%
EPS Next 3Y22.59%
EPS Next 5Y22.05%
Revenue Next Year15.45%
Revenue Next 2Y14.08%
Revenue Next 3Y13.66%
Revenue Next 5Y13.28%
3.3 Evolution
- Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 37.57, which means the current valuation is very expensive for DXCM.
- Based on the Price/Earnings ratio, DXCM is valued a bit cheaper than the industry average as 71.51% of the companies are valued more expensively.
- DXCM is valuated rather expensively when we compare the Price/Earnings ratio to 28.25, which is the current average of the S&P500 Index.
- With a Price/Forward Earnings ratio of 27.76, DXCM can be considered very expensive at the moment.
- Based on the Price/Forward Earnings ratio, DXCM is valued a bit cheaper than the industry average as 72.58% of the companies are valued more expensively.
- DXCM is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 27.50, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.57 | ||
| Fwd PE | 27.76 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DXCM indicates a somewhat cheap valuation: DXCM is cheaper than 73.12% of the companies listed in the same industry.
- 83.33% of the companies in the same industry are more expensive than DXCM, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.67 | ||
| EV/EBITDA | 23.53 |
4.3 Compensation for Growth
- DXCM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- DXCM has an outstanding profitability rating, which may justify a higher PE ratio.
- DXCM's earnings are expected to grow with 22.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.37
PEG (5Y)1.28
EPS Next 2Y23.51%
EPS Next 3Y22.59%
5. Dividend
5.1 Amount
- DXCM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:DXCM (2/5/2026, 3:54:06 PM)
69.88
-0.94 (-1.33%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-30 2025-10-30/amc
Earnings (Next)02-12 2026-02-12/amc
Inst Owners99.77%
Inst Owner Change-4.27%
Ins Owners0.19%
Ins Owner Change0.62%
Market Cap27.25B
Revenue(TTM)4.52B
Net Income(TTM)720.70M
Analysts85.95
Price Target87.62 (25.39%)
Short Float %3.98%
Short Ratio2.96
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.05%
Min EPS beat(2)5.32%
Max EPS beat(2)6.77%
EPS beat(4)2
Avg EPS beat(4)-0.91%
Min EPS beat(4)-11.66%
Max EPS beat(4)6.77%
EPS beat(8)6
Avg EPS beat(8)4.61%
EPS beat(12)10
Avg EPS beat(12)13.69%
EPS beat(16)11
Avg EPS beat(16)6.53%
Revenue beat(2)2
Avg Revenue beat(2)0.74%
Min Revenue beat(2)0.61%
Max Revenue beat(2)0.88%
Revenue beat(4)2
Avg Revenue beat(4)0.02%
Min Revenue beat(4)-1.2%
Max Revenue beat(4)0.88%
Revenue beat(8)2
Avg Revenue beat(8)-0.92%
Revenue beat(12)5
Avg Revenue beat(12)-0.38%
Revenue beat(16)6
Avg Revenue beat(16)-0.58%
PT rev (1m)-1.03%
PT rev (3m)-14.2%
EPS NQ rev (1m)0.41%
EPS NQ rev (3m)-4.21%
EPS NY rev (1m)0.07%
EPS NY rev (3m)0.45%
Revenue NQ rev (1m)0.39%
Revenue NQ rev (3m)-0.7%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)0.4%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.57 | ||
| Fwd PE | 27.76 | ||
| P/S | 6.04 | ||
| P/FCF | 25.67 | ||
| P/OCF | 18.82 | ||
| P/B | 10 | ||
| P/tB | 10.39 | ||
| EV/EBITDA | 23.53 |
EPS(TTM)1.86
EY2.66%
EPS(NY)2.52
Fwd EY3.6%
FCF(TTM)2.72
FCFY3.9%
OCF(TTM)3.71
OCFY5.31%
SpS11.58
BVpS6.99
TBVpS6.73
PEG (NY)1.37
PEG (5Y)1.28
Graham Number17.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.61% | ||
| ROE | 26.44% | ||
| ROCE | 19.96% | ||
| ROIC | 15.72% | ||
| ROICexc | 77.75% | ||
| ROICexgc | 88.6% | ||
| OM | 18.41% | ||
| PM (TTM) | 15.96% | ||
| GM | 60.2% | ||
| FCFM | 23.51% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
ROICexc(3y)35.45%
ROICexc(5y)29.66%
ROICexgc(3y)40.94%
ROICexgc(5y)33.19%
ROCE(3y)14.28%
ROCE(5y)11.73%
ROICexgc growth 3Y55.18%
ROICexgc growth 5Y18.96%
ROICexc growth 3Y50.14%
ROICexc growth 5Y16.58%
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
F-Score5
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 2.36 | ||
| Debt/EBITDA | 1.2 | ||
| Cap/Depr | 158.02% | ||
| Cap/Sales | 8.55% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 134.63% | ||
| Profit Quality | 147.34% | ||
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.38 | ||
| Altman-Z | 5.15 |
F-Score5
WACC9.73%
ROIC/WACC1.62
Cap/Depr(3y)175.34%
Cap/Depr(5y)240.83%
Cap/Sales(3y)9.32%
Cap/Sales(5y)10.84%
Profit Quality(3y)97.76%
Profit Quality(5y)73.64%
High Growth Momentum
Growth
EPS 1Y (TTM)9.41%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%35.56%
EPS Next Y27.38%
EPS Next 2Y23.51%
EPS Next 3Y22.59%
EPS Next 5Y22.05%
Revenue 1Y (TTM)14.21%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%21.64%
Revenue Next Year15.45%
Revenue Next 2Y14.08%
Revenue Next 3Y13.66%
Revenue Next 5Y13.28%
EBIT growth 1Y28.95%
EBIT growth 3Y30.52%
EBIT growth 5Y33.11%
EBIT Next Year73.63%
EBIT Next 3Y36.37%
EBIT Next 5Y30.77%
FCF growth 1Y112.47%
FCF growth 3Y127.88%
FCF growth 5Y36.21%
OCF growth 1Y93.75%
OCF growth 3Y30.77%
OCF growth 5Y25.76%
DEXCOM INC / DXCM FAQ
Can you provide the ChartMill fundamental rating for DEXCOM INC?
ChartMill assigns a fundamental rating of 7 / 10 to DXCM.
Can you provide the valuation status for DEXCOM INC?
ChartMill assigns a valuation rating of 5 / 10 to DEXCOM INC (DXCM). This can be considered as Fairly Valued.
Can you provide the profitability details for DEXCOM INC?
DEXCOM INC (DXCM) has a profitability rating of 9 / 10.
Can you provide the PE and PB ratios for DXCM stock?
The Price/Earnings (PE) ratio for DEXCOM INC (DXCM) is 37.57 and the Price/Book (PB) ratio is 10.